India approves first dengue vaccine QDENGA for people aged 4-60 years

Updated On: 20 July, 2026 03:23 PM IST | New Delhi | IANS

The vaccine has been approved for individuals aged between 4 and 60 years and can be administered irrespective of whether a person has previously been infected with dengue

Listen to this article :

India has approved QDENGA, the country's first dengue vaccine, for individuals aged 4 to 60 years. File pic

India has approved its first dengue vaccine, with the Drug Controller General of India (DCGI) granting market authorisation to Takeda Biopharmaceuticals India's QDENGA, marking a significant milestone in the country's efforts to combat one of its most widespread mosquito-borne diseases, it was announced on Monday.

The vaccine has been approved for individuals aged between 4 and 60 years and can be administered irrespective of whether a person has previously been infected with dengue.